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Continued 26S proteasome dysfunction in mouse brain
cortical neurons impairs autophagy and the Keap1-Nrf2
oxidative defence pathway
Aslihan Ugun-Klusek1, Michael H Tatham2, Jamal Elkharaz3, Dumitru Constantin-Teodosiu4, Karen Lawler4, Hala Mohamed4,
Simon ML Paine5, Glen Anderson6, R John Mayer4, James Lowe7, E Ellen Billett1 and Lynn Bedford*,4
The ubiquitin–proteasome system (UPS) and macroautophagy (autophagy) are central to normal proteostasis and interdependent
in that autophagy is known to compensate for the UPS to alleviate ensuing proteotoxic stress that impairs cell function.
UPS and autophagy dysfunctions are believed to have a major role in the pathomechanisms of neurodegenerative disease.
Here we show that continued 26S proteasome dysfunction in mouse brain cortical neurons causes paranuclear accumulation of
fragmented dysfunctional mitochondria, associated with earlier recruitment of Parkin and lysine 48-linked ubiquitination of
mitochondrial outer membrane (MOM) proteins, including Mitofusin-2. Early events also include phosphorylation of p62/SQSTM1
(p62) and increased optineurin, as well as autophagosomal LC3B and removal of some mitochondria, supporting the induction of
selective autophagy. Inhibition of the degradation of ubiquitinated MOM proteins with continued 26S proteasome dysfunction at
later stages may impede efficient mitophagy. However, continued 26S proteasome dysfunction also decreases the levels of
essential autophagy proteins ATG9 and LC3B, which is characterised by decreases in their gene expression, ultimately leading to
impaired autophagy. Intriguingly, serine 351 phosphorylation of p62 did not enhance its binding to Keap1 or stabilise the nuclear
factor erythroid 2-related factor 2 (Nrf2) transcription factor in this neuronal context. Nrf2 protein levels were markedly decreased
despite transcriptional activation of the Nrf2 gene. Our study reveals novel insights into the interplay between the UPS and autophagy
in neurons and is imperative to understanding neurodegenerative disease where long-term proteasome inhibition has been
implicated.
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Efficient protein degradation is crucial for proteostasis. The
ubiquitin–proteasome system (UPS) and macroautophagy
(autophagy) are the two major cellular catabolic pathways.
The UPS is restricted to soluble proteins, whereas autophagy
is involved in the degradation of a wider variety of substrates,
including misfolded soluble proteins, protein aggregates and
cellular organelles. Autophagy is known to compensate for
impairment of the UPS and alleviate ensuing proteotoxic
stress that impairs cell function.1 The UPS is regulated by a
refined ubiquitin signalling system, tagging unwanted proteins
with ubiquitin chains as a signal for their degradation by the
26S proteasome.2 Autophagic degradation also has the ability
to be selective for its cargo via ubiquitin signalling, removing
aggregated proteins, organelles and intracellular microbes.3–5
Selective autophagy is coordinated by autophagy receptors
linking cargos tagged with ubiquitin chains to the autophago-
somal membrane. p62/SQSTM1 (p62) is a well-characterised
autophagy receptor, but additional receptors such as neigh-
bour of BRCA1 gene 1 (NBR1), nuclear dot protein 52 kDa
(NDP52) and Optineurin (OPTN) have been identified, and the
regulatory mechanisms of selective autophagy are emerging.
Recent evidence demonstrates that phosphorylation of p62
at multiple sites specifies its function in selective autophagy.
Phosphorylation of p62’s ubiquitin-associated (UBA) domain
at serine (S) 409 by unc-51-like autophagy-activating kinase 1
then S403 by TANK-binding kinase 1 and/or casein kinase 2
increases its binding affinity for ubiquitin, promoting transloca-
tion to the ubiquitinated cargo.6,7 Following phosphorylation
of the UBA domain of p62, S351 phosphorylation in the
Kelch-like ECH-associated protein 1 (Keap1)-interacting
region (KIR) by mammalian target of rapamycin complex 1
(mTORC1) takes place on ubiquitinated cargos. S351
phosphorylation of p62 increases its binding affinity for
Keap1, competitively inhibiting Keap1’s interaction with
nuclear factor erythroid 2-related factor 2 (Nrf2) and seques-
tering Keap1 on autophagic cargos, coupling selective
autophagy to activation of the Keap1–Nrf2 antioxidant path-
way via stabilisation of Nrf2.8,9 The transcription factor Nrf2 is
normally constitutively degraded by the UPS; its binding
partner Keap1 is a component of the E3 ubiquitin ligase
complex that ubiquitinates Nrf2.10 Stabilised Nrf2 moves into
the nucleus to activate the transcription of cytoprotective
genes.11
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Ubiquitin is found in the inclusion bodies in most neuro-
degenerative diseases, including Alzheimer’s disease (AD),
Parkinson’s disease and amyotrophic lateral sclerosis.12 The
characteristics of ubiquitin in this context remain unknown,
but increasing evidence makes it plausible that UPS and
autophagy dysfunctions cause aberrant accumulation of
proteins and neurodegeneration.13 Aging is the major risk
factor shared by sporadic neurodegenerative diseases and
studies show cellular protein degradation systems become
less efficient with age.14,15 Recently, a role for the UPS in AD
pathogenesis was firmly supported by pooled genome-wide
association studies.16 Furthermore, conditional knockout
studies in mice indicate that proteasomal and autophagic
degradation have a causal link to neurodegenerative diseases
in general.17–20 Understanding the interplay between and
contribution of the UPS and autophagy to proteostasis in
neurons is imperative to understanding neurodegenerative
disease. Here we investigate this in mouse brain cortical
neurons with 26S proteasome dysfunction. We demonstrate
short-term (early) 26S proteasome dysfunction induces
selective autophagy, but long-term (continued) dysfunction
decreases autophagy characterised by downregulation of
essential autophagy genes. Furthermore, despite 26S protea-
some dysfunction leading to S351 phosphorylation of p62 and
early transcriptional activation of Nrf2, the Nrf2 protein is not
stabilised in brain.
Results
26S proteasome dysfunction in mouse forebrain neu-
rons. 26S proteasome dysfunction was restricted to mouse
forebrain neurons by crossing floxed Psmc1 mice (Psmc1fl/fl),
an essential ATPase subunit of the 19S regulatory particle of
the 26S proteasome, with mice expressing Cre recombinase
under the control of the calcium calmodulin-dependent
protein kinase IIα (CamKIIα) promoter (Psmc1fl/fl;CaMKIIα-
Cre) as described previously.17 Here ubiquitin immunostain-
ing revealed sparse 26S proteasome-impaired neurons in
Psmc1fl/fl;CaMKIIα-Cre cortices at 2 weeks old; significant
accumulation of ubiquitinated proteins was evident from
3 weeks old (Supplementary Figure S1A), consistent with
previous observations.17 The levels of synaptic and neuronal
marker proteins were similar at 3 and 4 weeks old, but
significantly decreased in Psmc1fl/fl;CaMKIIα-Cre cortices by
6 weeks old, reflecting progressive synaptic dysfunction and
neurodegeneration (Supplementary Figure S1B).
Mitochondrial fragmentation and mitophagy in 26S
proteasome-impaired neurons. In a qualitative study, we
previously described 26S proteasome dysfunction in mouse
nigral neurons in vivo caused paranuclear accumulation of
morphologically abnormal mitochondria.21 Here we show
similar paranuclear accumulation of morphologically abnor-
mal mitochondria in cortical neuron electron micrographs
(EMs) and quantification analyses of mitochondria at
6 weeks old (Figure 1). Mitochondrial aspect ratio was signifi-
cantly decreased in Psmc1fl/fl;CaMKIIα-Cre (median= 1.41)
compared to control (median= 1.59) neurons, showing
mitochondria were shorter (Figure 1b). Quantification of
mitochondrial size showed mitochondria in Psmc1fl/fl;
CaMKIIα-Cre (median=1.04 μm) neurons were significantly
smaller than in control (median= 1.27 μm), confirming mito-
chondrial fragmentation (Figure 1c). Cytochrome oxidase IV
(COXIV) qualitative immunostaining showed paranuclear
accumulation of mitochondria from 3 weeks old, supporting
early mitochondrial events following 26S proteasome dys-
function (Supplementary Figure S2A).
As the accumulation and fragmentation of mitochondria in
26S proteasome-impaired neurons is similar to that in models
of mitophagy,22,23 we investigated autophagy in cortical
neuron EMs at 6 weeks old. Membrane-bound compartments
resembling autophagic vacuoles (AVs) of diverse morphology
(varied in size, content and electron density) corresponding
to autophagosomes/autophagolysosome-like bodies were
observed in 6-week-old Psmc1fl/fl;CaMKIIα-Cre neurons
(Figure 1d i–v and Supplementary Figure S3). AVs were
rarely observed in control neurons, but primary and secondary
lysosomes were evident (Figure 1d vi and vii). Quantification
revealed a significant increase in AVs and AVs containing
condensed and aggregated mitochondria in Psmc1fl/fl;CaM-
KIIα-Cre compared to control neurons (Figure 1e). Further-
more, a temporal immunoblotting analysis of the mitochondrial
inner membrane protein COXIV showed similar significantly
decreased levels of COXIV at 4 and 6 weeks old in Psmc1fl/fl;
CaMKIIα-Cre cortices, supporting early removal of mito-
chondria following 26S proteasome dysfunction (Supple-
mentary Figure S2B). COXIV levels were also significantly
decreased in Psmc1fl/fl;CaMKIIα-Cre cortices using urea lysis
buffer, indicating that the mitochondria in the paranuclear
aggregates were soluble in the total lysis buffer used (data not
shown).
Mitochondrial dysfunction in 26S proteasome-impaired
neurons. To determine whether fragmented mitochondria
in Psmc1fl/fl;CaMKIIα-Cre neurons were associated with
functional impairments, we measured mitochondrial mem-
brane potential (MMP) in freshly purified cortical mitochondria
using JC1 dye. Mitochondrial depolarisation is evident by
a decrease in red:green fluorescence ratio, which depends
only on the membrane potential and not other factors such
as mitochondrial size and shape. A significant decrease in
MMP was evident by 6 weeks old in Psmc1fl/fl;CaMKIIα-Cre
cortices compared with controls (Figure 2a). Further,
we observed significantly decreased complex I activity in
Psmc1fl/fl;CaMKIIα-Cre mitochondria at 6 weeks old, support-
ing mitochondrial dysfunction (Figure 2b).
MOM protein degradation is inhibited by 26S proteasome
dysfunction. Parkin-mediated lysine (K) 48-linked ubiquiti-
nation of mitochondrial outer membrane (MOM) proteins for
26S proteasomal degradation is important for efficient
mitophagy.22,23 Figure 3a shows Parkin on Psmc1fl/fl;CaM-
KIIα-Cre mitochondria is significantly increased at 3 weeks
old, but decreased at 4 and 6 weeks old. Total levels of Parkin
were not significantly different between control and Psmc1fl/fl;
CaMKIIα-Cre cortices at any age (data not shown). Figure 3b
shows significantly increased K48-linked ubiquitin chains
associated with purified Psmc1fl/fl;CaMKIIα-Cre mitochondria
from 3 weeks old, coinciding with Parkin recruitment and
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Figure 1 Mitochondrial fragmentation and mitophagy in 26S proteasome-impaired neurons. (a) Representative EMs of control (i) and Psmc1fl/fl;CaMKIIα-Cre (ii) cortical
neurons at 6 weeks old. Enlarged views of mitochondria in boxed areas are shown in (iii, control) and (iv, Psmc1fl/fl;CaMKIIα-Cre). n, nucleus; i, inclusion; m, mitochondria;
v, vesicle. Scale 2 μm (i and ii) and 500 nm (iii and iv). (b and c) Smoothed line frequency histograms of mitochondrial aspect ratio and size distribution respectively for control
and Psmc1fl/fl;CaMKIIα-Cre neurons. Po0.001 (b) and Po0.0001 (c) by Mann–Whitney test. (d) Representative AVs in 6-week-old Psmc1fl/fl;CaMKIIα-Cre cortical neurons
(i–v) with heterogeneous intraluminal contents; vesicles (i; v), amorphous material (ii; asterisk) and condensed mitochondria (ii-v; m). Aggregates of condensed mitochondria
resembling mitochondria undergoing autophagy are shown (iv and v; arrows). Representative primary (vi; pl) and secondary lysosomes (vii; sl) in 6-week-old control
cortical neurons. Scale 200 nm. (e) Quantification of the total number of AVs and AVs containing mitochondria in 6-week-old control and Psmc1fl/fl;CaMKIIα-Cre neurons. Error
bars represent S.E.M. **Po0.01 and ***Po0.001 by unpaired Student’s t-test. Quantification in Figure 1 used 18 randomly selected neurons from three different control and
Psmc1fl/fl;CaMKIIα-Cre brains
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increasing 26S proteasome dysfunction. 26S proteasome
complexes and activity gradually decrease between 2 and
4 weeks old in Psmc1fl/fl;CaMKIIα-Cre cortices.17 To further
our investigations of ubiquitinated proteins on mitochondria
we used immobilised UBA domain from Ubiquilin 1
(UBQLN1) to capture all ubiquitin chain linkage types from
control and Psmc1fl/fl;CaMKIIα-Cre cortices at 6 weeks
old followed by analysis via liquid chromatography tandem
mass spectrometry (Supplementary Figure S4 and
Supplementary Table S1). As expected, 26S proteasome
dysfunction caused global accumulation of ubiquitinated
proteins with most proteins showing increased abundance
in Psmc1fl/fl;CaMKIIα-Cre mice (Figure 3c). In all, 217
proteins identified mapped to proteins in the mouse Mito-
Carta inventory, highlighting a wide mitochondrial ubiquitome
(Supplementary Table S1). Specifically, we identified 46% of
the class 1 candidate Parkin-dependent targets revealed by
di-glycine profiling experiments and 21 known MOM ubiqui-
tination targets associated with the depolarisation- and
Parkin-dependent ubiquitome, including Mfn2 (Supple-
mentary Table S1).24,25 Figure 3d shows increased ubiquiti-
nated Mfn2 in Psmc1fl/fl;CaMKIIα-Cre cortices from 4 weeks
old. Furthermore, di-glycine capture proteomics showed
K416 and K84 residues of Mfn2 were ubiquitinated as
previously described in the seminal study by Sarraf et al.25
only in mitochondria purified from Psmc1fl/fl;CaMKIIα-Cre
cortices, not control (Supplementary Table 1). Consistent with
previous studies, we identified increased ubiquitinated
autophagy receptors in Psmc1fl/fl;CaMKIIα-Cre cortices,
including p62, NBR1 and Tax1-binding protein 1 (Supple-
mentary Table S1, Supplementary Figures S4 and S5).22,24,25
Interestingly, ubiquitinated Ambra1 was one of the most
significantly increased proteins in Psmc1fl/fl;CaMKIIα-Cre
cortices captured by UBQLN1 (Supplementary Table S1,
Supplementary Figures S4 and S5). Ambra1 has a role in the
induction of autophagy as a component of the Beclin1
(BECN1)-phosphoinositide 3-kinase complex and proteaso-
mal degradation of Ambra1 was recently shown to inhibit the
induction of autophagy.26,27
26S proteasome dysfunction induces selective auto-
phagy, but continued dysfunction decreases essential
autophagy proteins. As well as ubiquitin signalling, selec-
tive autophagy is regulated by molecular receptors such
as p62 and OPTN.3–5,28 Phosphorylation of p62 specifies its
role as a selective autophagy receptor. Here we show that
Figure 2 Mitochondrial dysfunction in 26S proteasome-impaired neurons. (a) Relative MMPof mitochondria purified from 3, 4 and 6-week-old control and Psmc1fl/fl;CaMKIIα-
Cre cortices using JC1 potentiometric dye. MMP is calculated as the ratio red:green fluorescence. Protonophore carbonyl cyanide m-chlorophenyl hydrazine (CCCP) was used
as a control; n≥ 3 mice. (b) Relative complex I activity of mitochondria purified from 3, 4 and 6-week-old control and Psmc1fl/fl;CaMKIIα-Cre cortices. Rotenone was used as a
control; n≥ 8 mice. Error bars represent S.E.M. in (a) and (b). **Po0.01 by unpaired Student's t-test
Figure 3 MOM protein degradation is inhibited by 26S proteasome dysfunction. (a) Western blots and quantification of Parkin on mitochondria purified from control and
Psmc1fl/fl;CaMKIIα-Cre cortices at 3, 4 and 6 weeks old. COXIV was used as a loading control at each age for quantification; a representative COXIV is shown. Error bars
represent S.E.M. of n= 3 mice. *Po0.05 and **Po0.01 by unpaired Student's t-test. (b) K48 polyubiquitin (polyUb) Western blots of mitochondria purified from control and
Psmc1fl/fl;CaMKIIα-Cre cortices at 3, 4 and 6 weeks old. Quantification used COXIV as a loading control at each age; a representative COXIV is shown. COXIV and LDH are
shown for both mitochondria and cytosol to demonstrate mitochondrial purity. Threefold less cytosol was loaded to prevent overexposure with α-K48 ubiquitin. Efficiency of
isolation procedure was also quantified by measuring mitochondrial and cytosol-specific marker enzymes citrate synthase and LDH respectively in total homogenate and then
cytosol and mitochondria following the procedure (materials and methods). Error bars represent S.E.M. of n= 3 mice. ***Po0.001 by unpaired Student's t-test. (c) Scatter plot
showing log2 ratio of abundance of ubiquitinated proteins in 6-week-old control and Psmc1
fl/fl;CaMKIIα-Cre cortices and -log10 P-value of t-test. In all, 1885 proteins were
identified; 1504 were significantly different between experimental groups (red markers). Relative intensities of ubiquitin, Mfn2, p62 and Ambra1 are highlighted. UBQLN1 and
USP2 shown for comparison. (d) UBQLN1 capture of ubiquitinated Mfn2 in control and Psmc1fl/fl;CaMKIIα-Cre cortices at 3, 4 and 6 weeks old using immunoblotting of
independent samples from (c); n= 3 mice. Specificity of the UBQLN1 pull-down is demonstrated using control beads without the UBQLN1 UBA domain. Although there is some
Mfn2 binding to control beads this is not significant as shown by the pixel density (bottom image) at 6 weeks old and is similar for both control and Psmc1fl/fl;CaMKIIα-Cre cortices
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the total p62 protein levels were not significantly different
between control and Psmc1fl/fl;CaMKIIα-Cre cortices, but the
levels of S403 and S351 phosphorylated p62 were
significantly increased in Psmc1fl/fl;CaMKIIα-Cre cortices
from 3 weeks old, indicative of early induction of selective
autophagy (Figure 4a). Figure 4a also shows significantly
Impaired autophagy and Keap1-Nrf2 oxidative defence
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Figure 4 26S proteasome dysfunction induces selective autophagy, but continued dysfunction decreases essential autophagy proteins. (a) Representative immunoblots and
quantification at 3, 4 and 6 weeks old of control and Psmc1fl/fl;CaMKIIα-Cre cortices. Short and long exposures for LC3B are shown. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as a loading control at each age for quantification; a representative GAPDH is shown. Error bars represent S.E.M. of n≥ 3 mice. *Po0.05 and **Po0.01 by
unpaired Student’s t-test. (b) CathD activity in 3, 4 and 6-week-old control and Psmc1fl/fl;CaMKIIα-Cre cortices. Pepstatin Awas used as a control and decreased CathD activity to
zero values (data not shown). Error bars represent S.E.M. of n= 5 mice. *Po0.05 by unpaired Student’s t-test. (c) ATG9 and LC3B gene expression in control and Psmc1fl/fl;
CaMKIIα-Cre cortices at 3, 4 and 6 weeks old. Error bars represent S.E.M. of n= 8 mice. *Po0.05 by unpaired Student’s t-test
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increased levels of OPTN in Psmc1fl/fl;CaMKIIα-Cre cortices
from 3 weeks old, supporting selective autophagy induction.
Levels of NBR1 were not significantly different between
control and Psmc1fl/fl;CaMKIIα-Cre cortices (data not shown).
We found elevated phosphorylated p62 and OPTN asso-
ciated with mitochondria purified from Psmc1fl/fl;CaMKIIα-Cre
cortices, substantiating the induction of mitophagy
(Supplementary Figure S6). Increased levels of phosphory-
lated p62 and OPTN are also found in the cytosol and likely
associated with protein aggregates that accumulate in 26S
proteasome-impaired neurons as well (Supplementary
Figure S6). S403 and S351 phosphorylated p62 displayed
prominent perinuclear puncta in Psmc1fl/fl;CaMKIIα-Cre
neurons at 3 weeks old (Supplementary Figure S7). At
6 weeks old, S403 phosphorylated p62 showed more diffuse
staining associated with inclusions, whereas S351 phos-
phorylated p62 puncta were more prominent and localised
to a single paranuclear area (Supplementary Figure S7).
To further investigate autophagy, we evaluated several
essential proteins in control and Psmc1fl/fl;CaMKIIα-Cre
cortices; ATG9, BECN1 and LC3B. Levels of ATG9 were
markedly decreased at 6 weeks old in Psmc1fl/fl;CaMKIIα-Cre
cortices (Figure 4a). BECN1 levels were not significantly
different between control and Psmc1fl/fl;CaMKIIα-Cre cortices
at any age (Figure 4a). LC3B-II was significantly increased at
3 weeks old in Psmc1fl/fl;CaMKIIα-Cre cortices, indicative of
early induction of autophagy, but no significant differences
were observed at 4 and 6 weeks old (Figure 4a). LC3B-I levels
were similar at 3 weeks old, but significantly decreased in
Psmc1fl/fl;CaMKIIα-Cre cortices at 4 and 6 weeks old, which
together with decreased ATG9 suggests autophagy is
decreased with continued 26S proteasome dysfunction
(Figure 4a). Investigations of the lysosomal proteolytic
enzyme cathepsin D (CathD) revealed that, despite similar
levels of the mature protein (Figure 4a), CathD activity was
significantly increased in Psmc1fl/fl;CaMKIIα-Cre cortices at 3,
4 and 6 weeks old (Figure 4b), suggesting this may be the
result of a regulatory modification that enhances its proteolytic
activity.29
LC3B-II is itself degraded by autophagy, which may explain
some of the decrease in total LC3B protein levels in Psmc1fl/fl;
CaMKIIα-Cre cortices, but ATG9 is thought to be recycled from
the autophagosomal membrane.30,31 To clarify whether the
decreased levels of ATG9 and LC3B proteins were due to
enhanced autophagic degradation or transcriptional regula-
tion, we measured their gene expression in control and
Psmc1fl/fl;CaMKIIα-Cre cortices. ATG9 and LC3B gene
expression levels were significantly decreased in 6-week-old
Psmc1fl/fl;CaMKIIα-Cre cortices, supporting downregulation of
autophagy (Figure 4c).
Continued 26S proteasome dysfunction in neurons
impairs the Keap1-Nrf2 pathway. We recently showed
26S proteasome dysfunction in hepatocytes activated selec-
tive autophagy and the Keap1-Nrf2 antioxidant path-
way via S351 phosphorylation of p62.9 Phosphorylated p62
and Keap1 proteins are degraded by autophagy. Here we
found significantly increased levels of Keap1 protein at 4
and 6 weeks old in Psmc1fl/fl;CaMKIIα-Cre cortices by
immunoblotting, suggesting impaired autophagic degradation
(Figure 5a). This is supported by the marked increase in
S351 phosphorylated p62 at 6 weeks old (Figure 4a).
Comparable accumulation of phosphorylated p62 and Keap1
was not observed in mice with hepatocyte-specific knockout
of Psmc1.8,9 Unexpectedly, 26S proteasome dysfunction
in neurons did not stabilise the Nrf2 protein. Nrf2 protein
levels in Psmc1fl/fl;CaMKIIα-Cre cortices were significantly
decreased in total extracts from 4 weeks old, as well as
nuclear extracts at 6 weeks old (Figure 5a). Consequently,
haem oxygenase-1 (HO-1) and NAD(P)H dehydrogenase
quinone 1 (NQO1) proteins, major targets of Nrf2, were
also markedly decreased at 6 weeks old (Figure 5a).
However, we found Nrf2 gene expression was significantly
increased in Psmc1fl/fl;CaMKIIα-Cre cortices at 4 and 6 weeks
old (Figure 5b). To rationalise our observations, we investi-
gated the binding of p62 and Keap1 in Psmc1fl/fl;CaMKIIα-Cre
cortices by co-immunoprecipitation. Figure 5c shows less
p62 co-immunoprecipitated with Keap1 in Psmc1fl/fl;CaMKIIα-
Cre cortices, suggesting p62 phosphorylation does not
enhance p62 binding to Keap1 in this in vivo neuronal
context.
Discussion
In this study, we show early induction of selective autophagy
following 26S proteasome dysfunction in vivo, but with
continued 26S proteasome dysfunction the levels of core
autophagy proteins ATG9 and LC3 decreased associated with
their decreased gene expression, which may be an adaptive
response to prolonged autophagy induction. The increasing
levels of autophagy substrates Keap1 and phosphorylated
p62 with continued 26S proteasome dysfunction also support
impaired autophagic degradation.8,32,33 Autophagy has a
diverse range of protective roles, that is, during starvation,
degradation of protein aggregates and dysfunctional
organelles.34,35 However, numerous studies have reported
the notion of autophagic cell death (ACD) where over-
activation of autophagy leads to excessive degradation of
important cellular components and cell death.36 Therefore, the
outcome may depend on the extent of autophagy induction
and cellular context. Neurons may be sensitive to ACD
because of their efficient autophagic flux.37 Autophagy is
generally considered to compensate for proteasomal dys-
function and alleviate subsequent proteotoxic stress.1 These
studies have been carried out in cellular models using
pharmacological inhibitors of the 20S proteasome and involve
short-term 20S proteasome inhibition. In our study, induction
of autophagy following short-term (early) 26S proteasome
dysfunction likely has a protective role, but continued 26S
proteasome dysfunction may trigger excessive autophagy.
The observed downregulation of essential autophagy genes
provides a mechanistic response to terminate autophagy.
Transcriptional regulation of ATG genes is a key aspect
modulating autophagy activity.38,39 Our results are supported
by a recent study showing that sustained proteasome knock-
down in primary culture and larval skeletal muscle inhibited
autophagosome formation observed with short-term protea-
some inhibition.40
Extensive work has focused on the PTEN induced putative
kinase 1 (PINK1) kinase-Parkin ubiquitin ligase mitochondrial
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Figure 5 26S proteasome dysfunction in neurons impairs the Keap1-Nrf2 pathway. (a) Representative immunoblots and quantification at 3, 4 and 6 weeks old of control and
Psmc1fl/fl;CaMKIIα-Cre cortices. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control at each age for quantification; a representative GAPDH is
shown. An immunoblot is also shown for Nrf2 in nuclear extracts at 3, 4 and 6 weeks old; TATA-binding protein TBP (TBP-TATA) was used as a loading control at each age for
quantification. Error bars represent S.E.M. of n≥ 3 mice. *Po0.05 and **Po0.01 by unpaired Student’s t-test. (b) Nrf2 gene expression in control and Psmc1fl/fl;CaMKIIα-Cre
cortices at 3, 4 and 6 weeks old. Error bars represent S.E.M. of n= 8 mice. **Po0.01 and ***Po0.001 by unpaired Student’s t-test. (c) Immunoprecipitation of control and
Psmc1fl/fl;CaMKIIα-Cre cortical homogenates at 3, 4 and 6 weeks old with Keap1 antibody followed by western blotting with Keap1 and p62 antibodies. The amount of Keap1
immunoprecipitated was similar in control and Psmc1fl/fl;CaMKIIα-Cre mice at 3, 4 and 6 weeks old; therefore, the Keap1 image (6-week-old) is representative of all ages
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quality control pathway (mitophagy) that involves the UPS and
autophagy.41,42 Upon depolarisation, PINK1 is stabilised on
theMOMwhere it recruits and activates cytosolic Parkin via an
elaboratemechanism involving PINK1-dependent phosphory-
lation of ubiquitin and Parkin.24,43 Parkin markedly changes
the mitochondrial ubiquitome, promoting the assembly of
ubiquitin chains of multiple linkage types on numerous
mitochondrial proteins, some for 26S proteasomal degrada-
tion. Our results show that the upstream events of mitophagy
are activated in Psmc1fl/fl;CaMKIIα-Cre neurons. We suggest
Parkin is recruited from the cytosol to dysfunctional mitochon-
dria before or at 3 weeks old and moves back to the cytosol
at later stages following ubiquitination of MOM proteins,
including the known Parkin-dependent target Mfn2. In agree-
ment with previous reports using 20S proteasome inhibitors,
increasing 26S proteasome dysfunction inPsmc1fl/fl;CaMKIIα-
Cre neurons with age inhibits the degradation of ubiquitinated
MOM proteins and downstream events of mitophagy, that is,
efficient removal of dysfunctional mitochondria.22,23 Protea-
somes are long-lived cell constituents and appear to be in
excess.44 Our previous studies showed 26S proteasome
complexes and activity gradually decrease between 2 and
4 weeks old in Psmc1fl/fl;CaMKIIα-Cre cortices.17 Therefore,
residual 26S proteasome function between 3 and 4 weeks old
may degrade ubiquitinatedMOMproteins, includingMfn2, and
contribute to the removal of some dysfunctional mitochondria
at early stages. Studies in cultured cells have been instru-
mental in discovering the role of the PINK1/Parkin pathway in
mitochondrial quality control. To our knowledge, only two
previous studies have investigated this pathway in neurons
in vivo using mouse models of mitochondrial dysfunction.45,46
Pickrell et al. recently provided strong evidence that the
PINK1/Parkin pathway is active in brain. Our study provides
further evidence of a role for this pathway in neurons in vivo
and 26S proteasomal degradation of at least some MOM
proteins may have a direct role in autophagic degradation of
mitochondria. It is possible that decreased levels of essential
autophagy proteins with continued 26S proteasome dysfunc-
tion in neurons contributes to inefficient removal of mitochon-
dria. Immunohistochemical investigations of Parkin, as well as
PINK1 and phospho-ubiquitin investigations were unsuccess-
ful because of inadequate antibodies available for mice.
The roles of and spatiotemporal relationships between
the receptors that regulate selective autophagy is still unclear.
Here we show 26S proteasome dysfunction in cortical
neurons is associated with increased phosphorylated p62
and OPTN on mitochondria, which taken together with
increased LC3B-II and removal of some mitochondria, is
indicative of selective autophagic degradation of ubiquitinated
cargo at early stages. However, we cannot exclude the
possibility that a late block in the normal high flux through the
autophagy pathway in neurons may also lead to increased
LC3B-II at this stage. p62 links ubiquitinated cargo with
autophagosomes via its UBA domain and LC3-interacting
region (LIR), respectively. As p62 itself is degraded in
autolysosomes, the levels of p62 are used as an index of
autophagic status. However, p62 protein changes are often
cell type and context dependent, and this may be complicated
by transcriptional regulation of p62.47 We did not observe
changes in the total levels of p62 protein inPsmc1fl/fl;CaMKIIα-
Cre cortices and it is possible that p62 is transcriptionally
regulated in neurons in this context. However, we show
increased phosphorylation of p62’s UBA domain, which has
recently been confirmed to specify its function in selective
autophagy by increasing its binding affinity for ubiquitin and
regulating selective autophagic degradation of ubiquitinated
proteins and mitochondria.7,48 OPTN is a more novel
autophagy receptor and was recently shown to function in
PARKIN-dependent mitophagy, binding to ubiquitinated mito-
chondria via its ubiquitin binding in ABIN (A20 binding and
inhibitor of NF-κB) and NEMO (NF-κB essential modulator)
domain and inducing autophagosome assembly via its LIR.49
We found elevated OPTN associated with mitochondria in
Psmc1fl/fl;CaMKIIα-Cre cortices, which may indicate the
induction of mitophagy.
Unexpectedly, despite the marked increase in S351
phosphorylated p62, we did not find evidence of enhanced
p62 binding to Keap1 or stabilisation of the Nrf2 protein.
Interestingly, although groups have shown strong evidence
that p62 phosphorylation is involved in selective autophagy,
phosphorylation of both the UBA and KIR has not been
reported together. Our data together with previous studies
shows UBA phosphorylation in response to proteotoxic stress
and supports a role in the regulation of selective autophagy in
neurons in vivo.6,7,50 S351 phosphorylation of the KIR of p62 is
thought to occur downstream of S403 phosphorylation and
increases affinity between p62 and Keap1, coupling the
Keap1-Nrf2 and selective autophagy pathways.8 Recent
studies describing activation of these pathways, including
following Psmc1 inactivation, have been in liver.8,9 S403
phosphorylated p62 has not been reported in autophagy-
deficient liver to our knowledge. Autophagy is a tissue-
specific, context-dependent process and our data may be
explained by physiological differences between hepatocytes
and neurons. It is also possible that phosphorylation of both
the UBA and KIR of p62 affects binding between p62 and
Keap1. Further, p62 may be involved in other complexes in
Psmc1fl/fl;CaMKIIα-Cre neurons that affect its interaction with
Keap1.51
The Nrf2 antioxidant pathway is activated at the transcrip-
tional level in brain following 26S proteasome dysfunction, but
the levels of Nrf2, as well as its target proteins decrease.
Proteostasis relies on delicate interplay between protein
synthesis and degradation. Therefore, continued 26S protea-
some dysfunction may attenuate protein synthesis. Studies
have shown that proteasome inhibition has an impact on
eukaryotic translation initiation factor 2α and mTORC1; two
important regulators of protein synthesis, leading to repres-
sion of translation.52–54 Nrf2 protein levels may be post-
transcriptionally regulated bymicroRNAs.55 miR-144, miR-28,
miR-200 and miR-34 have all been shown to fine tune the Nrf2
pathway.56 Importantly, it is also possible that neuroprotective
antioxidant defences other that Nrf2 may be activated in brain,
which is a mixed cell population, in response to proteotoxic
stress. We previously showed that the astrocytic antioxidant
enzyme peroxiredoxin 6 has an important role in response to
early oxidative stress caused by neuronal 26S proteasome
dysfunction. Therefore, activation of Nrf2 may not be
necessary in this context.57
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Ubiquitin is found in the inclusions in most neurodegenera-
tive diseases and increasing evidence makes it plausible that
UPS and autophagy dysfunctions have a causal link.13
Therefore, understanding the interplay between and contribu-
tion of the UPS and autophagy to proteostasis in neurons is
imperative to understanding neurodegenerative disease.
Our study reveals novel insights into proteostasis in neurons;
26S proteasomal degradation regulates autophagy. Similar to
previous studies, we also show that short-term 26S protea-
some dysfunction activates autophagy, but continued dys-
function in neurons leads to impaired autophagy and
ultimately proteostasis collapse and cell death. Our findings
are significant in the context of human disease where long-
term proteasome dysfunction has been implicated and the
enhancement of proteasome activity may be a promising
strategy for the treatment of disease.
Materials and Methods
Mice. Generation of conditional 26S proteasome-deleted mice has been
described in detail previously.17 Appropriate littermate mice were used as controls
(Psmc1fl/fl;CaMKIIα-Wt and Psmc1fl/wt;CaMKIIα-Wt). All procedures were carried
out under personal and project licences granted by the UK Home Office in
accordance with the Animals (Scientific Procedures) Act 1986 and with ethical
approval from the University of Nottingham Ethical Review Committee.
Electron microscopy. Mice were perfusion-fixed with 0.9% saline followed by
glutaraldehyde fixative suitable for EM. A JEOL JEM-1400 120 kV Transmission
Electron Microscope (JEOL UK Ltd., Welwyn Garden City) with a Deben AMT XR80
digital camera (Deben UK Ltd., Bury St Edmunds, UK) was used. Mitochondrial
length or aspect ratio was quantified as the ratio between the major and minor axes
of the ellipse equivalent to the mitochondrion; the ratio has a minimum value of 1
when it is a perfect circle and the value increases when mitochondria become
elongated.58 Quantification of mitochondrial size was measured as their perimeter.
Measurements were performed using Image J (http://imagej.nih.gov/ij/).
Purification of mitochondria. Mitochondria were purified from freshly
dissected cortices and all steps were on ice. Each cortex was homogenised in ice-
cold buffered sucrose solution (2 mM HEPES pH 7.4, 210 mM mannitol, 70 mM
sucrose, 0.1 mM EDTA, 1% (v/v) protease inhibitor cocktail (Sigma-Aldrich,
Gillingham, UK, P8340)) using a Dounce tissue grinder (Fisher Scientific,
Loughborough, UK). This was termed the total homogenate. Total homogenates
were centrifuged at 500 g for 10 min followed by a further 10-min centrifugation at
1000 g of the re-suspended pellet in buffered sucrose solution. The resulting pellet
was termed the nuclear-enriched fraction. Supernatants were combined and
centrifuged at 7000 g for 10 min. The resulting supernatant was termed the
cytosolic fraction. The pellet was re-suspended in buffered sucrose solution and
centrifuged at 7000 g for a further 10 min; this was repeated and the supernatants
discarded. The pellet was re-suspended in buffered sucrose solution and layered
onto a sucrose gradient of 60, 32, 23 and 15% sucrose in 10 mM MOPS (pH 7.2),
1 mM EDTA. Gradients were centrifuged at 130 000 g for 60 min at 4 °C and
mitochondria were collected from the 32–60% interface and centrifuged at 10 000 g
for 10 min at 4 °C to pellet the mitochondria. Pellets were then washed twice with
buffered sucrose solution before re-suspending in buffered sucrose solution for
storage; all fractions were stored at − 80 °C.
The efficiency of mitochondrial purification was quantified by measuring the activity
of mitochondrial and cytosol-specific marker enzymes citrate synthase and lactate
dehydrogenase (LDH), respectively, in total homogenate and then cytosol and
mitochondria following the procedure. This consistently showed approximately fivefold
purification of mitochondria. We also performed COXIV and LDH western blot assays.
Pull-down assay. Bacterial expression plasmids (pGEX-4T-1) encoding GST-
UBA of UBQLN1 (VRFQQQLEQLSAMGFLNREANLQALIATGGDINAAIERLLGS)
were kindly provided by Dr. Robert Layfield (Nottingham University, Nottingham,
UK). Fusion proteins were expressed in XL-10 Escherichia coli strain, purified using
glutathione sepharose beads (GE Healthcare, Amersham, UK, 17-0756-01) and
UBQLN1 protein released by thrombin (Sigma-Aldrich T6884) cleavage. Purified
UBQLN1 was then coupled to cyanogen bromide activated sepharose-4B beads
(Sigma-Aldrich, C9142) in coupling buffer (100 mM NaHCO3, 500 mM NaCl, pH
8.3) followed by blocking with 1 M ethanolamine (pH 8). Control beads with no
protein coupled were also prepared in parallel. For the pull-down assay, cortices
were homogenised in buffer containing 50 mM Tris, 150 mM NaCl, 0.5% (v/v)
Igepal, 5 mM N-ethylmaleimide, pH 7.5, 0.1% (v/v) protease and phosphatase
inhibitors (Sigma-Aldrich, P5726) and 20 μM MG-132 (Enzo Life Sciences, Exeter,
UK, BML-PI102) using a bead beater (MP bio FastPrep®-24, MP Biomedicals, UK).
Samples were centrifuged at 16 000 g for 20 min at 4 °C. Protein concentration was
determined using Bradford protein assay. Dithiothreitol was added to each sample to
a final concentration of 10 mM. Typically 5 mg of protein homogenate was added to
30 μl of beads and incubated overnight at 4 °C with gentle mixing. Beads were then
washed six times for 10 min each with 20 volumes of wash buffer (50 mM Tris,
150 mM NaCl and 0.5% (v/v) Igepal, pH 7.5). For mass spectrometry (MS) analysis,
beads were re-suspended in deubiquitinating enzyme USP2 elution buffer (USP2;
50 mM Tris-HCl, 1 mM DTT, pH 7.4) and incubated overnight at 37 °C. Beads were
collected by centrifugation and supernatant transferred to an Eppendorf for MS
analysis. For western blotting, interacting proteins were eluted directly from the
beads in sodium dodecyl sulphate-polyacrylamide gels (SDS-PAGE) sample buffer.
Label-free mass spectrometry-based proteomic analysis of
UBQLN1-interacting proteins. Triplicate samples from the three experi-
mental groups, control beads+Psmc1fl/fl;CaMKIIα-Cre cortices, UBQLN1 beads
+control cortices and UBQLN1 beads+Psmc1fl/fl;CaMKIIα-Cre cortices, were
fractionated by SDS-PAGE (NuPage 10% polyacrylamide, Bis-Tris with MOPS
buffer) and tryptic peptides extracted.59 MS analysis was performed by a benchtop
orbitrap mass analyser (Q Exactive, Thermo Fisher Scientific, Waltham, MA, USA)
equipped with an integrated nano-electrospray (Easy-Spray Thermo Fisher
Scientific) coupled to a nano-uHPLC system (Easy N-LC-1000 Thermo Fisher
Scientific). Peptides were fractionated on a 50 cm x 75 μm ID, PepMap RSLC C18,
2 μm reverse phase column run at 45 oC, fractionating over 150 min (exact details
of gradient available upon request). Data were acquired in the data-dependent
mode to automatically switch between MS and MS/MS acquisition. Full scan spectra
(m/z 300–1800) were acquired in the orbitrap with resolution R= 70 000 at m/z 200
(after accumulation to a target value of 1 000 000 or 20 ms). The 10 most intense
ions were fragmented by HCD (resolution 17 500 at m/z 200 and target value of
1 000 000 or 60 ms). MS raw data files were processed by MaxQuant (www.
maxquant.org).60 Owing to the extreme stringency of the ubiquitin purification
procedure that uses a ubiquitin-specific affinity reagent (UBQLN1), and a ubiquitin-
specific elution reagent (USP2), the control bead samples contained very low
protein amounts. Furthermore, because Psmc1 inactivation causes a massive
global shift in protein ubiquitination, the vast majority of proteins in the Psmc1fl/fl;
CaMKIIα-Cre UBQLN1 purifications were more abundant than in the control
equivalents. These two facts meant that MaxLFQ intensities could not be used
because of the LFQ algorithm being dependent on the majority of proteins not
changing in abundance across samples. Raw intensity values were normalised by
median ratios within groups. Only proteins with three intensity values reported in at
least one of the experimental groups were carried forward for analysis. In addition,
decoy proteins, those likely to be external contaminants and proteins identified only
by modified peptides were rejected. This left 1885 proteins. Any proteins identified in
the UBQLN1 pull-downs without three intensity values in one group, but with three in
the other (such as three from Psmc1fl/fl;CaMKIIα-Cre samples, but only one in
control), had zero intensity values replaced using Perseus (using parameters width
0.3 downshift 0.8, separately for each sample). These intensity values were used to
calculate two samples t-test P-values comparing UBQLN1 pull-downs from Psmc1fl/
fl;CaMKIIα-Cre and control samples. The average of three ratios and –log10 P-value
of the t-test were used to create the volcano plot shown in the Figure 3.
PTMScan ubiquitin remnant motif (K-ε-GG) kit. Di-glycine-modified
lysine residues were captured from purified mitochondria using the PTMScan
Ubiquitin Remnant Motif (K-e-GG) kit according to the methods provided by Cell
Signalling (New England Biolabs, Hitchin, UK).
Preparation of total protein extracts. Mouse cortices were homogenised
in total lysis buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1 mM MgCl2, 100 mM
NaF, 10% glycerol, 1% Triton X-100, 1% Na deoxycholate, 0.1% SDS, 125 mM
sucrose and 1% (v/v) protease inhibitor cocktail) or urea lysis buffer (30 mM Tris, 8
M urea, 4% CHAPS and 1% (v/v) protease inhibitor cocktail) using a bead beater
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(MP bio FastPrep-24). Samples were centrifuged at 10 000 g for 10 min at 4 °C.
Protein concentration was determined using Bradford protein assay.
Gel electrophoresis and western blotting. Equal protein was subjected
to electrophoresis on 8, 10 or 12% SDS-PAGE. Separated proteins were transferred
onto nitrocellulose membrane using the Bio-Rad wet blotting system (Biorad
Laboratories Ltd., Hemel Hempstead, UK). Equal protein loading was assessed by
staining with 0.05% copper(II) phthalocyanine in 12 mM HCl. Blotted membranes
were blocked for 1 h in 5% dried skimmed milk in Tris-buffered saline containing
0.1% (v/v) Tween-20 and then incubated overnight at 4 °C with primary antibodies
diluted in blocking solution. Membranes were washed and incubated for 1 h at room
temperature with appropriate horseradish peroxidise-conjugated secondary
antibodies (Sigma-Aldrich, A6154 or A4416) in blocking solution. Antibody binding
was revealed with enhanced chemiluminescence (ECL; Pierce, ThermoFisher
Scientific, Waltham, MA, USA, 32106) or ECL prime (GE Healthcare, Amersham,
UK, 2236) western blotting detection reagent. Digital images were captured using
FujiFilm LAS-3000 mini and band intensity was quantified using Aida software
(version 4.27.039, Elysia-raytest GmbH, Straubenhardt, Germany). Appropriate
loading controls were used for quantification as indicated in the figure legends.
Primary antibodies. SNAP25 (GTX113839), NSE (GTX101553), LDH
(GTX101416), NBR1 (GTX114539) and HO-1 (GTX101147) from GeneTex, Inc.
(Nottingham, UK); PSD95 (clone 6G6-1C9, MA1-045 ) from ThermoFisher Scientific
(Waltham, MA, USA); GAPDH (G9545) and LC3B (L7543) from Sigma-Aldrich; p62
(ab56416), Nrf2 (ab31163), NQO1 (ab34173), CathD (ab6313) and TATA-binding
protein TBP (ab51841) from Abcam (Cambridge, UK); Mfn2 (NBP1-96547), ATG9A
(NB110-56893), Ambra1 (NBP1-07124) and Beclin1 (NB500-249) from Novus
Biologicals (Abingdon, UK); Keap1 (10503-2-AP) from Proteintech (Manchester,
UK); COXIV (4844) and Parkin (4211) from Cell Signalling; p62-S403 (D343-3) and
p62-S351 (PM074) from Medical and Biological Laboratories Co., Ltd (Nagoya,
Japan); K48-linkage-specific polyubiquitin antibody (05-1308) from Millipore; OPTN
(H-220) (sc99214) from Santa Cruz (Heidelberg, Germany).
Immunohistochemistry. Mice were perfusion fixed with 0.9% saline followed
by 4% paraformaldehyde in phosphate-buffered saline (pH 7.4). Fixed brains were
processed to paraffin using chloroform as the clearing agent. Immunostaining was
performed as directed in Vector Laboratories M.O.M Immunodetection (PK2200) or
Vectastain Elite Rabbit IgG ABC kits (PK6101) (Vector Laboratories Ltd.,
Peterborough, UK). In all, 0.01 M citrate buffer containing 0.05% Tween-20 (pH
6) was used for antigen retrieval. Primary antibody incubation was for 1 h at room
temperature. Antibody binding was revealed using 3,3'-diaminobenzidine substrate
and sections were counterstained with hematoxylin.
Mitochondrial membrane potential. MMP was measured in freshly
purified cortical mitochondria using JC1 dye (Invitrogen, T-3168). Mitochondria were
incubated in 210 mM sucrose, 20 mM KCl, 3 mM glycylglycine, 1 mM KH2PO4 and
0.5 mM MgCl2 containing 30 mM glutamate, 20 mM malate and 7.5 μg/ml JC1 at
37 °C for 15 min in the dark. No stained samples were incubated in buffer without
JC1. In all, 1 μM CCCP (Sigma-Aldrich, Gillingham, UK, C2759) was added before
incubation at 37 °C as a control for mitochondrial depolarisation. Following
incubation, samples were washed with buffer and centrifuged at 10 000 g for 5 min
at room temperature. The resulting mitochondrial pellet was re-suspended in buffer
and fluorescent intensity analysed using a PHERAstar plate reader (BMG
LABTECH, Aylesbury, UK). JC1 displays green (Ex 490 nm, Em 530 nm) and red
(Ex 490 nm, Em 590 nm) fluorescence. JC1 forms aggregates exhibiting red
fluorescence when taken up by mitochondria with high membrane potential. MMP
was normalised to total mitochondrial protein.
NADH coenzyme Q reductase (NQR/complex I) assay. In all, 10 μl
of mitochondrial suspension was added to 290 μl XNA (5 mM KH2PO4, 5 mM
MgCl2.6 H20 and 5 mg albumin) and 25 μl XNB (5 mM KH2PO4, 5 mM MgCl2.6
H20, 5 mg human serum albumin and 7.1 mg saponin). This was incubated on ice
for 5 min. In total, 72 μl of this mixture was added to 75 μl of Reagent 7 (2.33 ml
master mix, 100 μl coenzyme Q1 (6 mM; Sigma-Aldrich C7956), 20 μl of Antimycin
A (0.6 mg/ml; Sigma-Aldrich A8674) and 50 μl of KCN (20 mM)) then a blank was
measured for 2 min at 340 nm. In all, 3 μl NADH (7.5 mM) was added and the
absorbance measured for 2 min at 340 nm. In total, 2 μl rotenone (10%; Sigma-
Aldrich R8875) was added to inhibit complex I (control) and absorbance was
measured for a final 2 min at 340 nm. NQR activity was calculated by adjusting for
inhibition of complex I by rotenone and normalised to total mitochondrial protein.
CathD activity. CathD activity was measured using the fluorometric kit from
Abcam (ab65302) following the manufacturers protocol. Activity was normalised to
total protein. Pepstatin A (Merck, Darmstadt, Germany) was used as a control to
inhibit CathD activity.
Real-time RT-PCR. Total RNA was extracted from approximately 25 mg of
cortical tissue using Tri Reagent (Sigma-Aldrich) and subsequently quantified
spectrophotometrically at 260 nm with RNA purity being determined as the ratio of
260/280 nm readings. Thereafter, first-strand cDNA synthesis was carried out
according to standard methodology. Transcripts were quantified by TaqMan PCR
using an ABI prism 7900 sequence detector (Applied Biosystems Inc., Foster City,
CA, USA) with 2 μl of cDNA, 18 μM of each primer, 5 μM probe and Universal
TaqMan 2x PCR Mastermix (Roche). Each sample was run in duplicate. Primers
and MGB TaqMan probes (Thermo Fisher Scientific) were chosen where possible
such that probes span over exon–exon boundaries to avoid genomic amplification
(Supplementary Table S2). Hydroxymethylbilane synthase was used as internal
control, and all genes of interest were labelled with the fluorescent reporter 5-
carboxyfluorescein. Thermal cycling conditions: 10 min at 95 °C, followed by 40
cycles at 95 °C for 10 s then 60 °C for 30 s. The relative gene expression in the
Psmc1fl/fl;CaMKIIα-Cre group compared with the control was calculated using the
2−ΔΔCt method.
Statistical analysis. Statistical analyses and P-values are specified in the
figure legends; n= biological replicates.
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